<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Tip 2 Diyabet &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tip-2-diyabet/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 00:22:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Tip 2 Diyabet &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Behavioral Counseling Boosts Long-Term Survival in Type 2 Diabetes</title>
		<link>https://bioengineer.org/behavioral-counseling-boosts-long-term-survival-in-type-2-diabetes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 00:21:45 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[fiziksel aktivite]]></category>
		<category><![CDATA[IDES_2 study** **Kısa açıklama:** 1. **Behavioral counseling:** Makalenin temel müdahalesi ve ana konusu. 2. **Type 2 diabetes survival:** Araştırmanın ana çı]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket: **davranışsal danışmanlık]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket (virgülle ayrılmış): **Behavioral counseling]]></category>
		<category><![CDATA[mortalite** **Açıklama:** 1. **davranışsal danışmanlık:** Çalışmanın temel müdahale yöntemi ve ana konusu. 2. **tip]]></category>
		<category><![CDATA[Mortality reduction]]></category>
		<category><![CDATA[Physical activity adherence]]></category>
		<category><![CDATA[Tip 2 Diyabet]]></category>
		<category><![CDATA[Type 2 diabetes survival]]></category>
		<category><![CDATA[uzun vadeli sağkalım]]></category>
		<guid isPermaLink="false">https://bioengineer.org/behavioral-counseling-boosts-long-term-survival-in-type-2-diabetes/</guid>

					<description><![CDATA[In a groundbreaking new study published recently in Nature Communications, researchers have unveiled compelling evidence supporting the long-term benefits of behavioral counseling on the mortality rates of individuals living with type 2 diabetes. This post hoc analysis, conducted on data from the Italian Diabetes and Exercise Study_2 (IDES_2), sheds new light on how structured behavioral [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319561</post-id>	</item>
		<item>
		<title>Linking Lymphatic Damage and Insulin Resistance in T2DM</title>
		<link>https://bioengineer.org/linking-lymphatic-damage-and-insulin-resistance-in-t2dm/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jan 2026 09:40:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[İnsülin direnci]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **lenfatik sistem]]></category>
		<category><![CDATA[Makalenin içeriği ve vurgulanan anahtar kavramlar dikkate alınarak en uygun 5 etiket: **Lenfatik sistem hasarı]]></category>
		<category><![CDATA[Tip 2 Diyabet]]></category>
		<category><![CDATA[Trigliserid-glukoz indeksi** **Açıklama:** 1. **Lenfatik sistem hasarı:** Makalen]]></category>
		<category><![CDATA[trigliserid-glukoz indeksi** **Açıklama:** 1. **lenfatik sistem:** Çalışmanın ana konusu olan lenfatik sistem hasarını doğrudan hedefler.]]></category>
		<category><![CDATA[Vasküler periadventisiyal tensör analizi]]></category>
		<category><![CDATA[vasküler periadventisyel tensor analizi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/linking-lymphatic-damage-and-insulin-resistance-in-t2dm/</guid>

					<description><![CDATA[In a groundbreaking study set to be published in 2026, researchers Xu, S., Wang, XY., and Yang, D. have delved into the complex relationship between lymphatic system damage and insulin resistance in patients suffering from Type 2 Diabetes Mellitus (T2DM). This study marks a significant leap in understanding how disturbances in the body’s lymphatic system [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314850</post-id>	</item>
		<item>
		<title>Insulin Resistance and Heart Function in New Diabetes</title>
		<link>https://bioengineer.org/insulin-resistance-and-heart-function-in-new-diabetes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 30 Dec 2025 12:17:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diyabetik kardiyovasküler risk** **Açıklama:** 1. **İnsülin direnci:** Makalenin temel araştırma konusu ve anahtar pat]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **İnsülin direnci]]></category>
		<category><![CDATA[Otomatik ekokardiyografi]]></category>
		<category><![CDATA[Subklinik sistolik disfonksiyon]]></category>
		<category><![CDATA[Tip 2 Diyabet]]></category>
		<guid isPermaLink="false">https://bioengineer.org/insulin-resistance-and-heart-function-in-new-diabetes/</guid>

					<description><![CDATA[In a groundbreaking study that promises to reshape our understanding of cardiovascular health in diabetes, a team of researchers has delved deep into the often-overlooked connection between insulin resistance and subclinical systolic dysfunction. The research, led by Li et al., highlights significant findings that explore these relationships through the innovative lens of automated functional imaging [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">312361</post-id>	</item>
		<item>
		<title>Optimizing Cardio-Metabolic Cut-offs for Diabetes Diagnosis</title>
		<link>https://bioengineer.org/optimizing-cardio-metabolic-cut-offs-for-diabetes-diagnosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 12 Dec 2025 04:28:57 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Kişiselleştirilmiş tıp** **Açıklama:** 1. **Kardiyo-metabolik indeksler:** Makalen]]></category>
		<category><![CDATA[Makalenin içeriğine ve anahtar vurgularına göre en uygun 5 etiket: **Kardiyo-metabolik indeksler]]></category>
		<category><![CDATA[Metabolik sendrom tanısı]]></category>
		<category><![CDATA[Optimal eşik değerler]]></category>
		<category><![CDATA[Tip 2 Diyabet]]></category>
		<guid isPermaLink="false">https://bioengineer.org/optimizing-cardio-metabolic-cut-offs-for-diabetes-diagnosis/</guid>

					<description><![CDATA[Recent advancements in the field of endocrinology have put a spotlight on metabolic syndrome, a condition that poses significant health risks, particularly in individuals diagnosed with type 2 diabetes. In a novel study conducted by Bazyar et al., researchers have sought to establish optimal cut-off values for various cardio-metabolic indices utilized in the diagnosis of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">306462</post-id>	</item>
		<item>
		<title>Semaglutide: Weekly Dose Boosts Diabetes Care in Japan</title>
		<link>https://bioengineer.org/semaglutide-weekly-dose-boosts-diabetes-care-in-japan/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 19 Nov 2025 01:04:29 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Haftalık Tedavi** * **Semaglutide:** Makalenin ana konusu olan ilaç. * **Tip 2 Diyabet:** Çalışmanın ve tedavinin odaklandığı hast]]></category>
		<category><![CDATA[İşte 5 uygun etiket (virgülle ayrılmış): **Semaglutide]]></category>
		<category><![CDATA[Japon Hastalar]]></category>
		<category><![CDATA[ORIGAMI Çalışması]]></category>
		<category><![CDATA[Tip 2 Diyabet]]></category>
		<guid isPermaLink="false">https://bioengineer.org/semaglutide-weekly-dose-boosts-diabetes-care-in-japan/</guid>

					<description><![CDATA[A groundbreaking study published in the journal Diabetes Therapy reveals critical insights into the management of Type 2 diabetes among Japanese patients. The research, titled “Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes: A Retrospective Observational Multicenter Study (ORIGAMI Study),” offers compelling data on the long-term use of Semaglutide, a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">298490</post-id>	</item>
	</channel>
</rss>
